본문 바로가기

연구소

연구논문 및 특허성과

  • Home
  • 연구소
  • 연구논문 및 특허성과

논문성과

암센터 국문 논문 목록
학술지 책임저자
제1저자
저자,논문명,학술지명,발간일;년도;페이지:통권(Impact Factor)
Concurrent nivolumab and external beam radiation therapy for hepatocellular carcinoma with macrovascular invasion: A phase II study Joong-Won Park
Joong-Won Park:김보현, 김태현, Hee Chul Park:조유리, 고영환. Concurrent nivolumab and external beam radiation therapy for hepatocellular carcinoma with macrovascular invasion: A phase II study JHEP REPORTS. 2023-12-21; 2024; 6(4):100991~. IF 8.3 (2022)
김보현
(표적치료연구과)
김태현
(방사선의학연구과)
Excessive recommendations on health screening in Korea: analysis of news media and Youtube content related to overdiagnosis 강은교
(암검진사업부)
강은교:강은교, HyoRim Ju:최주영. Excessive recommendations on health screening in Korea: analysis of news media and Youtube content related to overdiagnosis JOURNAL OF PUBLIC HEALTH. 2023-12-21; 2023; :~. IF 4.7 (2022)
강은교
(암검진사업부)
Disparities of health expenditure associated with the experience of admission in long-term care hospital among patients with colorectal cancer in South Korea: A generalized estimating equation 한규태
(암관리정책부)
한규태:손누리, Woo-Ri Lee:. Disparities of health expenditure associated with the experience of admission in long-term care hospital among patients with colorectal cancer in South Korea: A generalized estimating equation PLOS ONE. 2023-12-21; 2023; 18(12):e0296170~. IF 3.7 (2022)
손누리
(암관리정책부)
Trends in the incidence and survival outcomes of endometrial cancer in Korea: a nationwide population-based cohort study 임명철
(희귀ㆍ소아암연구과)
임명철, Young-Joo Won:Seung-Hyuk Shim:김지현, Jiwon Lim, Yeon Jee Lee, Hyeong In Ha. Trends in the incidence and survival outcomes of endometrial cancer in Korea: a nationwide population-based cohort study JOURNAL OF GYNECOLOGIC ONCOLOGY. 2023-12-19; 2023; 35:e32~. IF 3.9 (2022)
Seung-Hyuk Shim
Disparities in Cancer Incidence across Income Levels in South Korea 서민아
(암검진사업부)
서민아, Dong Wook Shin:Su-Min Jeong:정규원, 박주원, 김나연. Disparities in Cancer Incidence across Income Levels in South Korea CANCERS. 2023-12-18; 2023; 15(24):5898~. IF 5.2 (2022)
Su-Min Jeong
Secondary Malignancies in Multiple Myeloma in Korean Patients: A Nationwide Population-Based Study 엄현석
(혈액종양내과분과)
엄현석:Boyoung Park, 이은영:Junghyun Yoon, YoungJu Park. Secondary Malignancies in Multiple Myeloma in Korean Patients: A Nationwide Population-Based Study CANCER RESEARCH AND TREATMENT. 2023-12-18; 2023; :~. IF 4.6 (2022)
이은영
(혈액종양내과분과)
Relationship between patient outcomes and patterns of fragmented cancer care in older adults with gastric cancer: A nationwide cohort study in South Korea 한규태
(암관리정책부)
한규태:최동우, Seungju Kim:류광선, 김재호, 장윤정. Relationship between patient outcomes and patterns of fragmented cancer care in older adults with gastric cancer: A nationwide cohort study in South Korea JOURNAL OF GERIATRIC ONCOLOGY. 2023-12-16; 2023; 15(2):101685~. IF 3 (2022)
최동우
(데이터결합팀)
Comparison of survival outcomes between olaparib and niraparib maintenance therapy in BRCA-mutated, newly diagnosed advanced ovarian cancer 임명철
(희귀ㆍ소아암연구과)
임명철:김지현, Se Ik Kim :박은영, 박상윤, Eun Taeg Kim, Hyesu Kim, Sangeon Kim. Comparison of survival outcomes between olaparib and niraparib maintenance therapy in BRCA-mutated, newly diagnosed advanced ovarian cancer GYNECOLOGIC ONCOLOGY. 2023-12-16; 2023; 181:33~39. IF 4.7 (2022)
김지현
(산부인과)
Treatment-related cardiovascular events in patients with non-small cell lung cancer: Evidence from real-world data with a competing risks approach 조현순
(암AI디지털헬스학과)
조현순:Thi Ngoc Tran:이상희, 김학진, 이영주, Thao Minh Tu, 최진호, 송재원. Treatment-related cardiovascular events in patients with non-small cell lung cancer: Evidence from real-world data with a competing risks approach CANCER. 2023-12-16; 2023; 130(8):1303~1315. IF 6.2 (2022)
Tran Thi Ngoc
(암AI디지털헬스학과)
Structural insights into N-terminal methionine cleavage by the human mitochondrial methionine aminopeptidase, MetAP1D 김현숙
(표적치료연구과)
김현숙, Hyo Jung Kim:이연:김하영, 허윤영. Structural insights into N-terminal methionine cleavage by the human mitochondrial methionine aminopeptidase, MetAP1D SCIENTIFIC REPORTS. 2023-12-15; 2023; 13(1):22326~. IF 4.6 (2022)
이연
(표적치료연구과)